bened paper.jpg

New clinical study:
PS128 improves anxiety,
stress, and sleep



We research the microbiota-gut-brain axis, isolate novel probiotic strains, and

lead the psychobiotic industry.

  • 30M+

    doses sold

  • 25+

    clinical studies

  • 42+

    markets served

  • 80+ employees,


    in R&D

  • 38+

    patents globally


Strain discovery and isolation. Clinical research and development. Global production and distribution.  If you would like to work with us in any of these areas, we’d love to hear from you.

  • From basic research and clinical trials to pharmaceutical drug development

  • Production

    Finished-product ODM of customized formulations that contain novel probiotic strains

  • Distribution

    Collaborate to distribute our Inseed® brand probiotics in worldwide markets


Global presence

Our operations are managed from company headquarters in Taiwan, and strategically-located manufacturing partners help service more than 40 markets across the globe.

CMO location

Bened products available

Latest news

​益福生醫股份有限公司 | 精神益生菌

This website is intended only for business or research professionals. The information is not for the final consumer. Our products are not for diagnosing, preventing, treating, nor curing disease. The information on this site is based on our research and development and is reliable to the best of our knowledge. It should not replace any form of professional medical advice. Regulations may vary in each market, and producers and marketers should confer with local resources or authorities to verify local regulatory requirements.

©2020 Bened Biomedical  ​益福生醫股份有限公司